Immunic Inc

XNAS:IMUX  
0.78
-0.01 (-0.69%)
7:59:05 PM EDT: $0.78 0.00 (0.15%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immunic Inc Stock, XNAS:IMUX

1200 Avenue of the Americas, Suite 200, New York, New York 10036
United States of America
Phone: +1.332.255.9818
Number of Employees: 77
http://imux.com

Description

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn�s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm�s products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.